ÂÜÀòÂÒÂ×

Pierre Matricon has a diverse work experience spanning from 2013 to 2023. Pierre is currently working at Sosei Heptares as a Senior Scientist I, and previously held the position of Research Scientist at the same company from July 2021 to December 2022. Prior to that, they completed their PhD at Uppsala University - Department of Cell and Molecular Biology, where they conducted molecular simulations of GPCRs for structure-based ligand design and receptor function. Pierre also completed a Master's Thesis at Science for Life Laboratory/Dept. of Biochemistry and Biophysics, where they predicted binding thermodynamics for fragment ligands of the Adenosine Receptors using a Free Energy Perturbation Approach. Additionally, they completed internships at National Center for Scientific Research/University of Paris 11 - BioCIS and National Center for Scientific Research/University of Grenoble 1 - Department of Molecular Chemistry, where they characterized the binding mode of therapeutic ligands and conducted docking and molecular dynamics simulation studies of CK2 protein kinase with allosteric inhibitors, respectively. Pierre also completed a Bachelor's Thesis at National Center for Scientific Research/University of Grenoble 1 - Department of Molecular Chemistry, where they synthesized and characterized dinuclear complexes for molecular recognition.

Pierre Matricon began their education in 2010 at Aix-Marseille University, where they pursued a B2 degree in Molecular Innovations & BIOpharmaceutical sciences (IMBIO). Pierre completed this degree in 2012. In the following year, from 2012 to 2013, they attended Université Joseph Fourier (Grenoble I) and obtained a Chemistry-Biology Bachelor's degree. Continuing their academic journey, Pierre pursued an International Master's Degree in In Silico Drug Design from the University of Strasbourg / Paris Diderot University, which they completed between 2013 and 2015. Most recently, from 2016 to 2021, Pierre Matricon attended Uppsala University, where they obtained a PhD degree focusing on Structure-based GPCR ligand design using computational chemistry.